Chemclin Diagnostics Co., Ltd. (SHA:688468)
7.68
+0.22 (2.95%)
Mar 10, 2026, 2:54 PM CST
-2.78% (1Y)
| Market Cap | 2.94B |
| Revenue (ttm) | 353.32M |
| Net Income (ttm) | 56.49M |
| Shares Out | 394.59M |
| EPS (ttm) | 0.14 |
| PE Ratio | 53.94 |
| Forward PE | n/a |
| Dividend | 0.13 (1.68%) |
| Ex-Dividend Date | Jun 13, 2025 |
| Volume | 3,970,078 |
| Average Volume | 4,029,289 |
| Open | 7.51 |
| Previous Close | 7.46 |
| Day's Range | 7.50 - 7.69 |
| 52-Week Range | 6.04 - 9.12 |
| Beta | 0.08 |
| RSI | 40.29 |
| Earnings Date | Apr 29, 2026 |